Neocentromeres are functional centromeres located in non-centromeric euchromatic regions of chromosomes. The formation of neocentromeres results in conferring mitotic stability to chromosome fragments that do not contain centromeric alpha satellite DNA. We present a report of a prenatal diagnosis referred to cytogenetic studies due to ultrasound malformations such as large cisterna magna, no renal differentiation, hypotelorism and ventriculomegaly. Cytogenetic analysis of GTG-banded chromosomes from amniotic fluid cells and fetal blood cells revealed a de novo small supernumerary marker chromosome. Molecular cytogenetic studies using fluorescence in situ hybridization and comparative genomic hybridization showed this marker to be an inverted duplication of the distal portion of chromosome 13q which did not contain detectable alpha satellite DNA. The neocentromeric constriction was located at band 13q31. The presence of a functional neocentromere on this marker chromosome was confirmed by immunofluorescence with antibodies to centromere protein-C. The anatomopathologic study revealed a female fetus with facial dysmorphisms, low set ears and renal dysplasia. Ten small supernumerary neocentromeric chromosomes originating from the distal region of chromosome 13q have been reported to date. There are only three additional cases described with the location of the neocentromere in band 13q31. This is the first reported case detected prenatally.

1.
Alonso A, Mahmood R, Li S, Cheung F, Yoda K, Warburton PE: Genomic microarray analysis reveals distinct locations for the CENP-A binding domains in three human chromosome 13q32 neocentromeres. Hum Mol Genet 12:2711–2721 (2003).
2.
Amor DJ, Choo K: Neocentromeres: Role in human disease, evolution, and centromere study. Am J Hum Genet 71:695–714 (2002).
3.
Amor DJ, Bentley K, Ryan J, Perry J, Wong L, et al: Human centromere repositioning ‘in progress’. Proc Natl Acad Sci USA 27:6542–6547 (2004).
4.
Barbi G, Kennerknecht I, Wohr G, Avramopoulos D, Karadima G, Petersen MB: Mirror-symmetric duplicated chromosome 21q with minor proximal deletion, and with neocentromere in a child without the classical Down syndrome phenotype. Am J Med Genet 91:116–122 (2000).
5.
Choo KH: Centromere DNA Dynamics: Latent centromeres and neocentromere formation. Am J Med Hum Genet 61:1225–1233 (1997).
6.
Kaiser-Rogers KA, Davenport ML, Powell CM, Rao KW: A recombinant X chromosome with atypical centromere observed in a child with Turner syndrome. Am J Hum Genet 57(Suppl):A658 (1995).
7.
Karpen GH, Allshire RC: The case for epigenetic effects on centromere identity and function. Trends Genet 13:489–496 (1997).
8.
Knegt AC, Li S, Engelen JJ, Bijlsma EK, Warburton PE: Prenatal diagnosis of a karyotypically normal pregnancy in a mother with a supernumerary neocentric 13q21→13q22 chromosome and balancing reciprocal deletion. Prenat Diagn 23:215–220 (2003).
9.
Levy B, Papenhausen PR, Tepperberg JH, Dunn TM, Fallet S, et al: Prenatal molecular cytogenetic diagnosis of partial tetrasomy 10p due to neocentromere formation in an inversion duplication analphoid marker chromosome. Cytogenet Cell Genet 91:165–170 (2000).
10.
Li S, Malafiej P, Levy B, Mahmood R, Field M, et al: Chromosome 13q neocentromeres: molecular cytogenetic characterization of three additional cases and clinical spectrum. Am J Med Genet 110:258–267 (2002).
11.
Liehr T, Claussen U, Starke H: Small supernumerary marker chromosomes (sSMC) in humans. Cytogenet Genome Res 107:55–67 (2004).
12.
Liehr T, Utine GE, Trautmann U, Rauch A, Kuechler A, et al: Neocentric small supernumerary marker chromosomes (sSMC) – three more cases and review of the literature. Cytogenet Genome Res 118:31–37 (2007).
13.
Lo AW, Magliano DJ, Sibson MC, Kalitsis P, Craig JM, Choo KH: A novel chromatin immunoprecipitation and array (CIA) analysis identifies a 460-kb CENP-A-binding neocentromere DNA. Genome Res 11:448–457 (2001).
14.
Politi V, Perini G, Trazzi S, Pliss A, Raska I, et al: CENP-C binds the alpha-satellite DNA in vivo at specific centromere domains. J Cell Sci 15:2317–2327 (2002).
15.
Rooney DE, Czepulkowski BH (eds): Human Cytogenetics: A Practical Approach, 2nd ed (Oxford University Press, New York 1992).
16.
Satinover DL, Vance GH, VanDyke DL, Schwartz S: Cytogenetic analysis and construction of a BAC contig across a common neocentromeric region from 9p. Chromosoma 110:275–283 (2001).
17.
Schinzel A: Catalogue of Unbalanced Chromosome Aberrations in Man, 2nd ed (Walter de Gruyter, Berlin 2001).
18.
Tönnies H: Modern molecular cytogenetic techniques in genetic diagnostics. Trends Mol Med 8:246–250 (2002).
19.
Warburton PE, Dolled M, Mahmood R, Alonso A, Li S, et al: Molecular cytogenetic analysis of eight inversion duplications of human chromosome 13q that each contain a neocentromere. Am J Hum Genet 66:1794–1806 (2000).
20.
Warburton PE: Chromosomal dynamics of human neocentromere formation. Chromosome Res 12:617–626 (2004).
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.